Lodo Therapeutics is creating a best-in-class natural product drug discovery platform for the discovery, biosynthesis, and characterization of new, genetically encoded small molecules in order to significantly increase the number and diversity of natural products available to test as therapeutic agents against infectious diseases.
Investment Date: December 2015